TruthArchive.ai - Related Video Feed

Dr. Pretorius and a colleague discuss unusual clotting observed after COVID-19 vaccination, including embalmers reporting back pressure when introducing embalming fluid and the extraction of very long, congealed clots—six inches to several feet—as well as patients with long brachial clots. They note thousands of clotting reports in VAERS across all vaccine types, describing these clots as not normal. Some clots cause major emboli affecting circulation to the lungs, detected by scans and perfusion studies, while others are microclots with a branching pattern visible in imaging. A clinician also shared a photo of a clot with a complete branching pattern into medium and smaller vessels. Dr. Pretorius’ work is cited to explain the mechanism: spike protein can induce immediate clumping of proteins in platelet-poor plasma in the absence of platelets, a highly unusual clotting pathway not relying on the classical coagulation cascade. This is described as a proteinaceous, pseudo-amyloid–like clot. The spike protein is reported to circulate after vaccination, with studies in the Journal of Immunology showing spikes in circulation and exosomes up to four months after shots. Long-haul COVID data (Patterson’s study) reportedly shows S1 protein present in nonclassical monocytes in blood, suggesting persistence of spike protein, whether from infection or the vaccine, which can induce clotting pathways on its own. Dr. Pretorius discusses observations of upregulation of intercellular adhesion molecules (ICAMs) on leukocytes within clots, causing white blood cells to adhere in addition to fibrin, contributing to difficulty in dissolving these clots. Concerning treatment and detection, the speakers describe depletion of plasminogen, reducing the body’s ability to break down clots, and note that standard anticoagulants are less effective against these clots, which are described as amyloid-like and atypical. They emphasize that these are not the classical clotting pathways involving platelet activation and typical thrombin–fibrin cascades. They contrast this with expectations of standard clotting mechanisms and reference the unusual, non-classical pathway highlighted by Pretorius. The discussion also mentions the idea that spike protein in circulation can drive clotting without the usual platelet activation, and that some patients have continued to experience spike-related effects long after vaccination. They assert that vaccines were developed targeting the original Wuhan strain and may not cover Omicron; they suggest the shot’s risk-benefit balance is unfavorable given ongoing clotting, immune suppression, and cancer-inducing pathways, and they claim data indicate those who receive two or three shots may acquire Omicron at a higher rate than those unvaccinated. They conclude that the shot is expired for a virus that is no longer circulating in its original form and argue that vaccination induces dangerous pathologic processes with no protective benefit.

In this video, Dr. Ross Anderson discusses his findings on COVID crystals and clots in vaccinated individuals. He discovered these crystals in a sample of the COVID-19 vaccine and has since observed them in live blood exams of vaccinated individuals. The crystals have a unique appearance and are different from normal yellow crystals found in the blood. Dr. Anderson also discusses COVID clots, which have been documented by pathologists and have a distinct appearance. He raises questions about the potential health implications of these crystals and clots and mentions the phenomenon of shedding. Dr. Anderson concludes by encouraging viewers to do their own research on the topic.

Speaker: A lot of the analysis techniques that were being employed now on the white clots. And about three years ago, there was one piece of analyses that I came across just by accident, which was a thing called an ICP analysis, which is an analysis that determines the elements present in white clots. It was done by a gentleman in The USA called Mike Adams, who presented the findings of his initial white clot analysis from samples that Richard had provided him some almost three years ago now. And it surprised me what the findings were, because I have used the ICP analysis. It’s called Inductively Coupled Plasma Mass Spectrometry. Don't worry about the name. It's just a very well known piece of analytical equipment that you can rely upon to tell you what elements are there in the white clot and in what abundance. And what surprised me was in the analysis that Mike presented was a very the highest element they found was phosphorus, followed by sodium, tin, and later on sulphur, and carbon. And we also found that there were no normal blood marker elements present in the white clots. So, we've actually employed two laboratories in Europe, and there's a long reason behind that because I'm associated with people in Europe who do this kind of work. Anyway, we sent clot samples, they all ran ICP analyses. They found exactly the same results that Mike Adams found. We found aberrantly high levels of phosphorus, we found aberrantly high levels of sulphur, tin, sodium, and carbon. And being an organic chemist, I know a little bit about tin chemistry, because I used to sell tin catalysts, believe it or not, for polymerisation reactions. So I had to study the chemistry of tin. And I wondered why tin would be present in a white clot. So, obviously, we could not believe this first series of results. It's set about replicating the results in two separate labs, and they came back and said, you're right, there's high levels of phosphorus, tin, sulfon, carbon. So the next thing we did was to do an analysis called HPLC, High Performance Liquid Chromatography. And what this does is actually pulls apart the white clots and tells you what the protein components are. And surprisingly, we found that the highest level of proteins we found was fibrinogen. But the HPLC analysis actually will determine what kinds of fibrinogen chains are there. In a normal red blood clot, there's normally one to one to one ratio of the alpha chain, beta chain and gamma chain. We found in our white clots that the beta chain far exceeded the alpha chain and the gamma chain. And in fact, it was beta gamma alpha. So the alpha was the lowest proportion. Now, we're not biochemists, and we're not medically qualified in any way. But we can do simple research to find out why the fibrinogen content was so high. Fibrinogen forms fibrils. This is exactly why when John O'Learny first described the white clots as being calamari like, he is exactly correct. That's exactly the texture that fibrin will bring into a white clot. Okay, so from then on, we then ran some amino analysis results. My colleagues ran an amino acid analysis, and they found a high level of Praline, Aspartic acid, Lysine, a whole range of about 18 amino acids, all that have a phosphorus affinity. And as we said in the white clot, the element that has the highest concentration that we could confirm is porpoise. If you take time then to research the aberrant pathways that what they call excess phosphorylation will cause, it causes a whole range of problems in the human body. So we have determined, we think, the pathway to the formation of these white clots. We have three separate pieces of analysis, all confirming our findings. So we've now pieced together the formation of the white clots, and I'll come back to the very beginning. When we administer the injections, there is a lipid nanoparticle carrier, it's called a phospholipid. We found by our analysis that when the phospholipid releases the mRNA core of the lipid nanoparticle, at the very moment that it releases the core, it actually exposes a phosphorus head of the phosphorus lipid. The phosphor lipid reacts within the bloodstream naturally formed fibrinogen, and that's what's nucleating the white clot formation. Now we can prove all this. We've actually got over 200 peer reviewed papers confirming the pathway that I'm describing. And more importantly, once that initiation of the DSPC now the actual phospholipid that is encapsulating the lipid nanoparticle is a phospholipid called DSPC. I won't go into the name of it, but what it means is that that particular phospholipid we found, again through research, that it will liberate 80 to 90% of raw phosphorus heads as it releases the mRNA core. Those phosphorus heads all react with the fibrinogen in the bloodstream and they cause sandy blood. The reason you guys are seeing sandy blood and coffee grounds is that's the nucleation pathway to the final white clot formation. The other factor we found and proved the spike protein bonds to the phosphorylated fibrinogen. The body is generating methylcetiopridine generated spike, that spike in the bloodstream then starts to coagulate with the phosphorylated fibrinogen, and that feeds what we call a monomeric reaction that continues to grow. Those particles are free flowing in the blood and they find an anchor point. The anchor points they find are in fact the damaged endothelial layers. When an endothelial layer of the vascular system is damaged via inflammation and the cytokine storm that the spike protein generates, That opens up the natural phospholipid layer of the endothelial layer, and that forms anchor points for these nuclei. From these anchor points, that's when the clots begin to grow. So, I'm trying to encapsulate this in a very simple term. It's quite a complex number. Very

In this video, the speaker discusses the presence of white fibrous clots in bodies. They conducted a survey last year to determine if this phenomenon was real. The survey revealed that around 70% of embalmers were seeing these clots, with most of them noticing them after the rollout of vaccines in 2021. Some embalmers reported seeing these clots in up to 50% or more of the corpses they worked with. The speaker is currently conducting another survey to gather more information on what embalmers are observing in 2023.

Tom Haviland, a retired major in the US Air Force and an experienced embalmer, discusses the presence of white fibrous clots found in the circulatory systems of deceased individuals. These clots, which have been observed in a high percentage of corpses over the past three years, are believed to be made of amyloid protein and fibrin. Embalmers have noticed an increase in the size and prevalence of these clots, as well as an increase in microclotting or "coffee ground" clots. The data collected from embalmers suggests that these clots may be linked to the spike protein produced by the COVID-19 vaccines.

I mixed dental anesthetic with blood and saw tiny machines that are not platelets. These robots are building something, which is not normal. They are dead erythrocytes, not platelets. The robots are jumping around, not platelets. It's surprising to see these little robots working.

Unvaccinated blood has round, flowing blood cells, indicating good pH. White blood cells are large and active, suggesting a working immune system. Vaccinated blood shows blood cells stuck together with strange shapes and black fibrin lines, potentially causing blood clots, strokes, and heart attacks. White blood cells are tiny, indicating a compromised immune system, with fibrins present. The blood sample contains bacteria, parasites, and dead blood. The plasma is full of bacteria and parasites in numbers not normally seen. There are at least 5 to 8 different kinds of bacterium and parasites, overwhelming the immune system and leaving no time to clean up cancer cells. The plasma is crawling with organisms, which is not normal and is a ticking time bomb.

We invited the staff of the Giovannini studio to discuss their study on the blood of over a thousand people, including those who were inoculated and those who were not. They found that the blood of inoculated individuals showed alterations in shape and arrangement of red blood cells when observed under dark field microscopy. In a normal blood sample, the red blood cells are spherical and well-oxygenated, with no foreign bodies present. However, in the blood of inoculated individuals, they observed the presence of nanotube-shaped inclusions that attracted red blood cells, leading to potential circulatory issues. This phenomenon, known as impelamento, can have thrombogenic effects. This occurs specifically in the blood of inoculated individuals.

The clots being formed, we've run mass spectrometry on these clots. They don't look like normal clots. They don't have the same composition. They don't have fibrin. They don't have thrombin, which are normal things you would see in a normal coagulation cascade. They have, instead, all the fibrinogen chains—alpha, beta, and gamma. They have them in a strange differential where it's not one-to-one-to-one; it's about 36 to 16 to 4 by ratios. They're aberrantly cross-linked by sulfide bonds. There's a ton of tin for some reason. I don't know why there's tin in there, but there's a ton of tin in there and a ton of phosphorus. And the spike protein is actually coated in GLIKNAK, which is a phosphate donor. So that might explain all the phosphorus if it's providing the energetics or in some way by cleaving or creating phosphate bonds. So I think that that's a big problem because that's a slow progression of coagulopathy that's, I think, narrowing the lumens of the vascular system, which is contributing to some of the organ failure that we're seeing, some of the neurological symptomatology that we're seeing, some of the fatigue, and things of that nature. And then finally, the spike protein is shown to produce—it’s shown to induce misfolding of proteins and actually

I've examined blood samples and have observed anomalies in everyone I've tested, even myself. I'm now seeing things I never saw in un*vaxxed individuals before. I'm noticing unusual formations, like chains potentially building, which typically occurs when the blood is breaking down. These formations seem more noticeable during decomposition. What's interesting is that while the body decomposes, these anomalies don't. They change and morph into something else. The red blood cells are visible, but when these formations mass together, that's when they evolve or morph. It could happen at any moment.

I washed my slides and found similar anomalies in everyone, including myself, which I hadn't seen in the unvaccinated before. I observe my blood regularly, and I've noticed some unusual formations that resemble liver congestion. These changes seem to become more apparent as the body decomposes, yet the anomalies themselves do not decompose; they morph into different forms. The red blood cells are present, but when they gather into masses, they begin to evolve. This process hasn't started yet, but it could happen at any moment.

The speaker discusses the formation of white fibrous clots induced by the spike protein in the blood. These clots can lead to various health issues like heart attacks and strokes. The speaker mentions Nattokinase, an enzyme derived from fermented soy, which can break down fibrin and dissolve clots. They highlight that regions like Northern Japan, where fermented soy is consumed, have lower rates of heart disease and strokes. The speaker suggests trying Nattokinase as an enzymatic mechanism to break down clots before they worsen.

In this video, Richard Hirschman, an embalmer, discusses the abnormal blood clotting issues he has observed in bodies since early 2021. He shares that these clots are different from typical blood clots, as they are white, fibrous, and rubbery in texture. Hirschman believes that these clots may be caused by aberrant proteins resulting from the COVID vaccines. He emphasizes the need for further research and understanding of these clots and their potential impact on health. Another guest, Jamie, a funeral service professional, supports Hirschman's observations and urges people to critically evaluate the situation. The video also includes a discussion on the suppression of information and the need for scientific investigation.

We purchased spike protein subunit MFC tag from Sino Biological and prepared it using doubly distilled water. A stock solution (0.25 mg/ml) was created by adding 400 µl of diluent to 100 µg of spike protein. This was diluted to working solutions. We assessed different spike protein concentrations in platelet-poor plasma using fluorescence microscopy. A healthy blood sample was divided into four tubes with varying spike protein concentrations (1000, 100, 50, and 1 ng/ml). Samples were incubated for 30 minutes at room temperature. We're replicating this experiment. I'll extract blood, add PBS buffer, and the spike protein. Then we'll look at the fluorescence.

Our study investigates the impact of the SARS-CoV-2 spike protein on blood hypercoagulation. We used microscopy and mass spectrometry to examine the spike protein's interaction with platelets and fibrinogen. Results using platelet-poor plasma showed the spike protein may disrupt blood flow. Mass spectrometry revealed structural changes in beta and gamma fibrinogen, complement, and prothrombin after adding spike protein S1. These changes, similar to those observed in COVID-19 patient blood clots, showed resistance to trypsinization. We propose that the spike protein's presence in the bloodstream contributes to hypercoagulation in COVID-19 patients, potentially causing impaired fibrinolysis and persistent microclots. This finding has significant clinical implications. Our goal was to determine the spike protein's effects, as its interaction with these blood components warrants further investigation.

The spike protein, according to research in South Africa, induces fibrin from fibrinogen, forming the backbone of clotting in a way not previously seen. Unlike normal fibrin clots that are easily broken down, clots formed from COVID or the spike protein from the vaccine are difficult to break down, causing issues for many people. A cardiologist stated that in their decades of practice, they have never treated as many blood clots as in the last five years. These blood clots occur after the virus infection and the vaccine because the spike protein causes blood clots. Therefore, it is reckless to continue vaccinating people and loading the body with spike protein, causing more blood clots. According to a paper in Cell (July 2021), the nucleoprotein, not the spike protein, supplied broad and durable immunity for the prevention of infection. The speaker questions why the vaccine wasn't changed to target the nucleoprotein once this information came to light.

We tested different vaccines on blood slides to observe their effects. Pfizer caused immediate cell clearing, J&J led to cell clumping, and the cells became nonfunctional. The changes were rapid and significant, raising questions about the vaccines' impact on blood cells. More research is needed to understand these findings.

White fibrous clots found in the living and dead recipients of mRNA vaccines are being ignored, but research reveals their composition and cause. The spike protein mutates fibrin into jagged, misfolded, insoluble amyloid, similar to prionic infections. Microclots form and align into large white clots, initiated by spike protein fragments like spike 601. Prolene, a "kinker protein" added to the spike protein, causes misfolding, with proline being prevalent in the clots. A 2021 paper showed the SARS CoV-2 spike induces abnormal blood clots due to the fibrinogen beta chain. Plasma exposed to the spike protein is imbalanced, with the fibrinogen beta chain being dominant. These clots contain four times the normal amount of phosphorus, released from lipid nanoparticles. Similar clots in 1988 were caused by sulfur-based heparin, which was resolved by reducing sulfur content. A 2017 paper showed altered phosphorus levels cause cancer. Thomas Havilland, who shares this information, is being ignored by mainstream and alternative media. Undertakers are seeing massive white fibrous clots at record levels.

Okay, let's get started. I need to find the right tools to draw blood, so please be patient. I'll put the scope back on so we can watch. Here are some micrographs: healthy predlopod plasma, then the same plasma with spike protein added. We want to see if adding spike protein directly to healthy blood creates larger microclots than we see in the samples with the spike protein already present. We'll compare the images to see the effects.

I washed my slides and examined blood samples from everyone, including myself. I noticed some anomalies that I hadn't seen in unvaccinated individuals before. These anomalies appear when the blood starts breaking down, particularly during decomposition. Interestingly, while the blood changes, the anomalies do not decompose; instead, they morph into different forms. The red blood cells are present, but when they cluster together, they begin to evolve into something else. This transformation could happen at any moment.

The speaker has been sequencing clots and found real human DNA, showing a signature of neutrophil extracellular traps, a reaction occurring in sepsis when the immune system clots around foreign entities. This process takes free-circulating DNA into clotting structures, leaving a specific signature. Sequencing reveals patient genome sequences that might predispose them to clotting. While billions received shots, not everyone clotted, suggesting a subset has a bad reaction. Genetic predispositions in the clotting cascade may increase risk. Initial analysis of two clots shows high-impact variants in genes involved in fibrin formation and clotting. Kevin McCarran's work demonstrates some clots bind thiophlavin, a marker for amyloid, suggesting a potential amyloidosis issue. Pathology needs careful examination as it may underlie clotting problems. This information is being suppressed, but citations are provided for reference.

The speaker discusses the formation of clots induced by the spike protein in the blood. These clots can be white and fibrous, and they can vary in size. The speaker mentions that these clots can lead to heart attacks or strokes if they block the flow of oxygen in the body. They also mention an enzyme called Nattokinase, derived from fermented soy, which can break down fibrin and dissolve clots. The speaker suggests that using enzymatic mechanisms to break down clots early can prevent the accumulation of amyloid proteins and the worsening of clots.

In this video, the speaker discusses some findings from their investigations into COVID-19 vaccines. They mention a sample that showed no phosphorus, which could be experimental error. They also found small specks of copper in some vaccines, but the reason for this is unknown. The speaker then talks about their own experiment where they added the Pfizer vaccine to blood and observed discoloration and clumping of red blood cells. They suggest that this could be due to the cationic lipid in the vaccine coming into contact with cell membranes. They emphasize the importance of informed consent and the need for more research on these vaccine effects.

For those who appreciate science, here’s some insight. This image shows a normal cell, but after an injection, noticeable changes occur. White nanoparticles invade, altering the cells' appearance; they lose their round, normal shape. The final image illustrates blood cells that are no longer smooth and symmetrical, now covered with lumps and protrusions. This suggests a deliberate attack on human blood, as noted by experts like Dr. Sherry, Tim Penny, and Nobel laureate Luc Montagnier.